Panelists discuss how β-blockers remain foundational therapy for heart failure with reduced ejection fraction (using evidence-based agents like carvedilol, metoprolol succinate, or bisoprolol) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback